Estrogen Found…But at What Cost? The Reality Behind the Estradiol Patch Shortage

A few weeks ago, we covered the nationwide estrogen patch shortage — and what it means for the many of us who rely on these therapies to function, not just cope. At the time, it felt like a supply issue. Temporary. Inconvenient, yes — but manageable.

It’s different when it becomes personal.

For the past three weeks, I’ve been unable to fill my estradiol patch prescription at my local pharmacy. I did what so many of us are learning to do in this phase of life: plan ahead, advocate early, call around. I started dialing pharmacies before I was even close to running out, hoping to stay one step ahead of the shortage.

It didn’t matter.

Two weeks ago, I ran out — and went without.

And if you’ve ever found something that works — a regimen that steadies the ground beneath you — you know the hesitation that comes next. My patches, paired with micronized progesterone, were doing their job. My symptoms were managed. Predictable. Livable. The idea of switching — to an oral medication, a different topical, something unfamiliar — wasn’t just inconvenient. It felt like starting over.

So, I waited. And weighed my options. And, like many women, found myself navigating a system that doesn’t always account for the realities of our lives.

Then came a suggestion from a nurse practitioner: try a mail-order pharmacy.

Within minutes of searching, I found my exact dosage — Mylan estradiol patches — available through TelyRx. They offered both one- and three-month supplies, with the ability to reference an existing prescription (I used mine from Midi Health). Approval took less than 30 minutes. Shipping was immediate. My order arrived in under 48 hours.

Efficient. Seamless. Almost too easy.

Until the price.

More than $400 for a three-month supply (24 patches). Over $160 for one month (8 patches).

Let’s pause there…

Because what this experience made painfully clear is that access, in this moment, is not just about supply — it’s about cost. The medication exists. It can be found. It can even be delivered to your door within days.

But only if you can afford it.

I chose the three-month option, hoping that by the time I cycle through this supply, local pharmacies will stabilize, and prices will come back within reach. But I’m fully aware that this wasn’t a choice available to everyone.

And that’s the part we can’t ignore.

We are living in a moment where menopause care is finally entering the mainstream conversation — where innovation, telehealth, and new care models are expanding what’s possible. But experiences like this remind us that progress without equity is incomplete.

Because what good is access…if it’s out of reach?

So, I’m sharing this not just as an update — but as a reality check. If you’re navigating the same shortage, know that alternatives exist. But also know that the system, as it stands, still asks too much of too many.

And that’s something we should all be talking about.